Social media is spreading “misleading and dangerous information” about vaccines, according to a report from U.K. charity the Royal Society for Public Health. The organization has called for social platforms to clamp down on fake news about vaccines and point users toward reputable sources of information. (Irish Times)

Genentech has brought back former executive Alexander Hardy to fill its CEO position. Hardy previously led patient services and commercial operations for various therapeutic areas at Genentech, then left the company to head up global product strategy at Roche. (Pharmaphorum)

A nonprofit will offer 20 generic drugs to hospitals to address shortages. The group, Civica Rx, was formed by a consortium of hospitals including HCA Healthcare, the Mayo Clinic, and the Catholic Health Initiatives. It plans to offer up to 100 generics to its hospital members in the next three to five years. (Reuters)

An adviser to the FDA said the agency is at war with itself over opioids. Dr. Raeford Brown, who worked with the FDA on opioid drugs, said the agency is putting drug manufacturers ahead of the public health crisis. He suggested the FDA should stop approving opioid drugs. (The Guardian)

The FDA could keep working without funding if drug reviews are deemed essential to protecting lives. The agency is partially shut down and only has enough user-fee funds to keep working for the next few weeks. If the money runs out, the FDA would likely need to stop reviewing drug applications or find a new solution. (STAT)